NDLI: Outcomes of Citalopram Dosage Risk Mitigation in a Veteran Population.

Please wait, while we are loading the content...

Culture and PTSD: Trauma in Global and Historical Perspectiveedited by Devon E. Hinton and Byron J. Good. Philadelphia, University of Pennsylvania Press, 2015, 440 pp., \$75.00 (hardcover).

Year: 2016 Volume: 173 Issue: 8

Year: 2016 Volume: 173 Issue: 7

Year: 2016 Volume: 173 Issue: 6

Year: 2016 Volume: 173 Issue: 5

Year: 2016 Volume: 173 Issue: 4

Year: 2016 Volume: 173 Issue: 3

Year: 2016 Volume: 173 Issue: 2

Year: 2016 Volume: 173 Issue: 1

Year: 2015 Volume: 172

Year: 2014 Volume: 171

Year: 2013 Volume: 170

Year: 2012 Volume: 169

Year: 2011 Volume: 168

Year: 2010 Volume: 167

Year: 2009 Volume: 166

Year: 2008 Volume: 165

Year: 2007 Volume: 164

Year: 2006 Volume: 163

Year: 2005 Volume: 162

Year: 2004 Volume: 161

Year: 2003 Volume: 160

Year: 2002 Volume: 159

Year: 2001 Volume: 158

Year: 2000 Volume: 157

Year: 1999 Volume: 156

Year: 1998 Volume: 155

Year: 1997 Volume: 154

Year: 1995 Volume: 152

Year: 1994 Volume: 151

Year: 1985 Volume: 142

Outcomes of Citalopram Dosage Risk Mitigation in a Veteran Population.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Rector, Thomas S. Adabag, Selcuk Cunningham, Francesca Nelson, David Dieperink, Eric
Description	Author Affiliation: Rector TS ( From the Center for Chronic Disease Outcomes Research, the Division of Cardiology, and the Department of Psychiatry, Minneapolis VA Health Care System, and the Department of Medicine, University of Minnesota, Minneapolis); Adabag S ( From the Center for Chronic Disease Outcomes Research, the Division of Cardiology, and the Department of Psychiatry, Minneapolis VA Health Care System, and the Department of Medicine, University of Minnesota, Minneapolis); Cunningham F ( From the Center for Chronic Disease Outcomes Research, the Division of Cardiology, and the Department of Psychiatry, Minneapolis VA Health Care System, and the Department of Medicine, University of Minnesota, Minneapolis); Nelson D ( From the Center for Chronic Disease Outcomes Research, the Division of Cardiology, and the Department of Psychiatry, Minneapolis VA Health Care System, and the Department of Medicine, University of Minnesota, Minneapolis); Dieperink E ( From the Center for Chronic Disease Outcomes Research, the Division of Cardiology, and the Department of Psychiatry, Minneapolis VA Health Care System, and the Department of Medicine, University of Minnesota, Minneapolis)
Abstract	OBJECTIVE: A public safety communication issued by the Food and Drug Administration declared that citalopram dosages exceeding 40 mg/day were no longer considered safe because of a newly recognized risk of dosage-dependent QT interval prolongation. The authors compared the incidence of hospitalizations and mortality when higher dosages of citalopram were or were not reduced to ≤40 mg/day. METHOD: National electronic medical records compiled by the Veterans Health Administration were used to conduct a retrospective study of a population filling citalopram prescriptions for more than 40 mg/day when the safety communication was first issued in August 2011. Hospitalizations and mortality after dosages of citalopram were or were not reduced to ≤40 mg/day were compared using multivariable Cox regression. RESULTS: The at-risk cohort of 35,848 veterans (mean age, 58 years [SD=11]; 92% male) had citalopram prescriptions for 64 mg/day (SD=8.3), on average. Within 180 days after the safety communication was issued, 60% had filled prescriptions for ≤40 mg/day. All-cause hospitalizations or deaths were found to significantly increase after dosage reductions (adjusted hazard ratio=4.5, 95% CI=4.1-5.0), as were hospitalizations for depression or all-cause death (adjusted hazard ratio=2.2, 95% CI=1.8-2.6). Mortality did not decline (adjusted hazard ratio=1.0, 95% CI=0.8-1.3), and neither did hospitalizations for arrhythmias or all-cause deaths (adjusted hazard ratio=1.3, 95% CI=1.0-1.7). CONCLUSIONS: Reduction of prescribed citalopram dosages to a new safety limit was associated with a higher rate of hospitalization in a large patient population who had been treated with substantially higher dosages. Stipulating a safety limit for citalopram dosages before the benefits and risks of doing so were firmly established appears to have had unintended clinical consequences.
File Format	HTM / HTML
ISSN	0002953X
e-ISSN	15357228
Journal	American Journal of Psychiatry
Issue Number	9
Volume Number	173
Language	English
Publisher	American Psychiatric Association
Publisher Date	2016-09-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Psychiatry
Content Type	Text
Resource Type	Article
Subject	Psychiatry and Mental Health

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Variation in Veteran Identity as a Factor in Veteran-Targeted Interventions.

Datapoints: suicide rates in the Washington State veteran population.

The Applicability of Randomized Controlled Trials of Psychosocial Treatments for PTSD to a Veteran Population

Current Trends in Veteran Suicides – from 2001 to 2019

High-dose citalopram for cocaine dependence in veteran population-a pilot project.

Use of Stimulants and Performance Enhancers During and After Trauma Exposure in a Combat Veteran: A Possible Risk Factor for Posttraumatic Stress Symptoms.

Physical Activity, Suicide Risk Factors, and Suicidal Ideation in a Veteran Sample.

Citalopram-Induced Seizures in a Healthy Adult Taking an FDA-Approved Dosage: A Case Report

Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence

Outcomes of Citalopram Dosage Risk Mitigation in a Veteran Population.

Similar Documents

Variation in Veteran Identity as a Factor in Veteran-Targeted Interventions.

Datapoints: suicide rates in the Washington State veteran population.

The Applicability of Randomized Controlled Trials of Psychosocial Treatments for PTSD to a Veteran Population

Current Trends in Veteran Suicides – from 2001 to 2019

High-dose citalopram for cocaine dependence in veteran population-a pilot project.

Use of Stimulants and Performance Enhancers During and After Trauma Exposure in a Combat Veteran: A Possible Risk Factor for Posttraumatic Stress Symptoms.

Physical Activity, Suicide Risk Factors, and Suicidal Ideation in a Veteran Sample.

Citalopram-Induced Seizures in a Healthy Adult Taking an FDA-Approved Dosage: A Case Report

Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence

Outcomes of Citalopram Dosage Risk Mitigation in a Veteran Population.